Skip to content
Catalyst

PapersPMID:28753932

Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial.

Nutrients2017The record ↗

  1. Finding, moderate evidenceno difference foundProgression-free survival

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “When we compared PFS and OS between placebo and red ginseng groups, the mean values of PFS were 34.4 and 39.2 months in placebo and red ginseng groups, showing no difference (p = 0.448).”
    Study
    RCT
    Participants
    30
    Duration
    3 months
    Dose studied
    two 500 mg capsules three times a day (3000 mg per day) for three months
    Population
    Women with epithelial ovarian cancer who had completed six cycles of adjuvant taxane- and platinum-based chemotherapy with complete or partial response, 15 per arm

Study record

Design
randomised controlled trial
Species
human
Population
Patients with epithelial ovarian cancer (EOC) after cytoreductive surgery and six cycles of adjuvant taxane- and platinum-based chemotherapy; Korean red ginseng (steamed Panax ginseng Meyer, 6-year-old)
Participants
30
Comparator
placebo
Duration
84 days
Endpoints measured
17